Blue Oak Pharmaceuticals, Inc.
Waltham, United States · Founded 2018 · $10.8M raised
- Headquarters
- Waltham, Massachusetts
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- blueoakpharma.com
- Total Funding
- $10.8M
- Last Round
- $9.0M Series AFeb 2021
- Rounds
- 2
About
Blue Oak Pharmaceuticals is a CNS-focused drug discovery company developing first-in-class therapeutics for brain disorders including bipolar disorder, schizophrenia, and treatment-resistant depression. Their proprietary ADEPt™ platform rationally designs privileged chemotypes with CNS activity using computational filters and validated in vivo neurobiology assays. The company has partnered with Exscientia and PsychoGenics to accelerate neuropsychiatric drug development.
Summary
Blue Oak Pharmaceuticals, Inc. is a Biotech company based in Waltham, United States, founded in 2018. It has raised $10.8M in total across 2 rounds, most recently a $9.0M Series A round in Feb 2021. Investors include Unknown.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company